William Blair Predicts Astrana Health Q1 Earnings

Astrana Health, Inc. (NASDAQ:ASTH) – Research analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for Astrana Health in a report released on Wednesday, July 2nd. William Blair analyst R. Daniels forecasts that the company will post earnings per share of $0.34 for the quarter. The consensus estimate for Astrana Health’s current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health’s Q4 2026 earnings at $0.48 EPS.

ASTH has been the topic of a number of other research reports. Truist Financial reduced their target price on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Barclays assumed coverage on Astrana Health in a research note on Tuesday, April 1st. They issued an “equal weight” rating and a $36.00 target price on the stock. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $53.29.

Astrana Health Stock Up 2.5%

ASTH opened at $25.28 on Thursday. The stock has a market cap of $1.42 billion, a PE ratio of 35.10, a P/E/G ratio of 1.36 and a beta of 0.84. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54. Astrana Health has a 52 week low of $23.12 and a 52 week high of $63.20. The business’s fifty day simple moving average is $26.65 and its 200 day simple moving average is $30.76.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The business had revenue of $620.39 million during the quarter, compared to analysts’ expectations of $628.11 million. During the same quarter last year, the business posted $0.31 EPS. The company’s quarterly revenue was up 53.4% on a year-over-year basis.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Pilgrim Partners Asia Pte Ltd bought a new position in shares of Astrana Health during the fourth quarter valued at about $40,000. Quarry LP grew its stake in shares of Astrana Health by 35.5% during the fourth quarter. Quarry LP now owns 1,799 shares of the company’s stock valued at $57,000 after buying an additional 471 shares during the last quarter. Covestor Ltd grew its stake in shares of Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company’s stock valued at $62,000 after buying an additional 1,773 shares during the last quarter. US Bancorp DE grew its stake in shares of Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after buying an additional 4,656 shares during the last quarter. Finally, AlphaQuest LLC grew its stake in shares of Astrana Health by 144.2% during the first quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock valued at $151,000 after buying an additional 2,883 shares during the last quarter. 52.77% of the stock is owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.